Chinese English Japanese Korean

ShangHai Biochempartner Co.,Ltd

Firmenname:ShangHai Biochempartner Co.,Ltd
Telefon:177-54423994
E-Mail:2853530910@QQ.com
Nationalität:China
URL: www.biochempartner.com
Produkte insgesamt:8000
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

Produktkatalog

1-Piperidinamine, N-hydroxy-N-nitroso-56329-24-9C5H11N3O2
Ozoralizumab1167985-17-2
Blosozumab1132758-87-2
Sirukumab1194585-53-9
Enoticumab1192578-27-0
Vandortuzumab Vedotin1471985-92-8
Afasevikumab1589503-30-9
Amivantamab2171511-58-1
JQKD-822410512-38-6C27H40N4O5
ML3392579689-83-9C26H32ClN3O5
INE9632640567-43-5C19H26N6O2S
OTX 008286936-40-1C52H72N8O8
Enoblituzumab1353485-38-7
SBI-4251451272-71-1C13H12ClN3O4S
2,4-Dichlorophenoxyacetyl chloride(2,4-Dichlorphenoxy)acetylchlorid774-74-3C8H5Cl3O2
Mc-Val-Ala-PAB-PNP1639939-40-4C32H37N5O10
Tregalizumab1207446-68-1
Flanvotumab1188277-05-5
Clazakizumab1236278-28-6
Tafasitamab1422527-84-1
AZD-1940881413-29-2C20H29F2N3O2S
Bocidelpar2095128-20-2C25H27F3N2O3
NCC0072342583-66-6C22H28F3N7
Lirilumab1000676-41-4
Sigma-1 receptor antagonist 21639220-15-7C20H26ClN3O2
Onartuzumab1133766-06-9
Indatuximab Ravtansine1238517-16-2
Quilizumab1228538-47-3
Tesidolumab1531594-08-7
Rovalpituzumab1613313-01-1
Xentuzumab1417158-65-6
AZ322288709-96-4C20H16N4O
JYN423461903742-34-6C27H24BrN7O3
TH54272253744-56-6C20H20Cl2N8O3
MRTX17192630904-45-7C23H18ClFN6O2
Zunsemetinib1640282-42-3C25H22ClF2N5O3
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione1380532-27-3C10H11F3N2O5
Crenezumab1095207-05-8
Tabalumab1143503-67-6
Fasinumab1190239-42-9
Lacutamab2187368-16-5
Indusatumab Vedotin1514889-12-3
Tisotumab1418628-81-5
Olendalizumab1337966-73-0
NCGC00378430920650-00-6C22H23N3O5S
Apostatin-12559703-06-7C19H27N3OS
Ublituximab1174014-05-1
Narnatumab1188275-92-4
Demcizumab1243262-17-0
Imgatuzumab959963-46-3
Lokivetmab1533403-95-0
Rinucumab1569263-06-4
Tilavonemab2096513-89-0
GI 181771305366-98-7C34H31N5O6
Ponezumab1178862-65-1
Caplacizumab915810-67-2
Actoxumab1245634-25-6
Refanezumab1233953-61-1
SUC-ALA-ALA-PRO-PHE-PNA107409-54-1C30H34N6O8
Ro60-0175169675-08-5C11H12ClFN2
AMG-131315224-26-1C21H12Cl4N2O3S
Boc-Val-Ala-PAB-PNP1884578-00-0C27H34N4O9
Ficlatuzumab1174900-84-5
Vatelizumab1238217-55-4
Futuximab1310460-85-5
Andecaliximab1518996-49-0
Nemolizumab1476039-58-3
Satralizumab1535963-91-7
Blontuvetmab1608112-78-2
FTO-IN-32585198-87-2C12H10N4OS
BioE-11971268863-69-9C20H18FN3O2
SR16641338259-05-4C33H29N3O5
Patritumab1262787-83-6
Vesencumab1205533-60-3
Pateclizumab1202526-59-7
Duligotuzumab1314238-96-4
Ligelizumab1322627-61-1
Evinacumab1446419-85-7
Ensitrelvir fumarate2757470-18-9C22H17ClF3N9O2.C4H4O4
RY7851393748-80-5C21H20N4O2S
Urelumab934823-49-1
Erucin4430-36-8C6H11NS2
Radretumab1253180-81-2
Inclacumab1256258-86-2
Bezlotoxumab1246264-45-8
Dectrekumab1528523-94-5
Ifabotuzumab1234137-51-9
Mirvetuximab1453084-36-0
SCD1 inhibitor-31282606-48-7C19H16FN7O2
2,4-Imidazolidinedione, 5-[3-[[4-[(3-methylphenyl)methoxy]phenyl]thio]-2-furanyl]-877176-23-3C21H18N2O4S
YM150365462-23-3C27H30N4O4
Biotinyl Cystamine128915-82-2C14H26N4O2S3
Risankizumab1612838-76-2
Solitomab1005198-65-1
Isatuximab1461640-62-9
Cabiralizumab1613144-80-1
Tamtuvetmab1608122-71-9
GSK2512125968-05-8C29H37FN6O4S
YTX-4652225824-53-1C25H26N6O3
(R)-GSK-36850322170140-50-6C22H24N6OS
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2019 © ChemicalBook. All rights reserved